AQR Capital Management - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 103 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q1 2022$536,000
-60.6%
129,996
+22.8%
0.00%
-50.0%
Q4 2021$1,361,000
+563.9%
105,868
+457.0%
0.00%
Q3 2021$205,000
-44.9%
19,007
-53.3%
0.00%
-100.0%
Q2 2021$372,00040,7430.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,102,929$18,059,047,0004.95%
Svennilson Peter 3,102,934$18,059,0002.29%
Casdin Capital, LLC 2,270,000$13,211,0001.40%
FRAZIER MANAGEMENT LLC 2,061,758$11,999,0001.36%
Redmile Group, LLC 3,068,194$17,857,0000.50%
Alphabet Inc. 929,022$5,407,0000.36%
Bleichroeder LP 169,039$984,0000.26%
Leap Investments LP 14,400$84,0000.12%
DAFNA Capital Management LLC 50,000$291,0000.12%
Blackstone Inc. 2,567,445$14,943,0000.11%
View complete list of GRITSTONE ONCOLOGY INC shareholders